COMMUNIQUÉS West-GlobeNewswire

Fortrea Completes Acquisition of the Early Phase Services Division from Worldwide Clinical Trials
19/10/2026
Expands Fortrea’s early clinical development network with dedicated bioanalytical capabilities, increased clinical research unit capacity and a more integrated platform for clients Highlights Fortrea completes [...]
CRISPR Therapeutics Announces Chief Financial Officer Transition
19/10/2026
ZUG, Switzerland and BOSTON, Oct. 19, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP) today announced that its Chief Financial Officer, Raju Prasad, Ph.D., will be stepping down from the Company to pursue [...]
Integra Announces Completion of Refinancing Transactions
19/10/2026
PRINCETON, N.J., Oct. 19, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that it has closed a private offering of $450.0 million aggregate principal amount of 9.500% [...]
City Therapeutics Announces Closing of $230.0 Million Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
19/10/2026
CAMBRIDGE, Mass., Oct. 19, 2026 (GLOBE NEWSWIRE) -- City Therapeutics, Inc. (Nasdaq: CTY) (“City” or “City Therapeutics”), a clinical-stage biotechnology company developing the next generation of RNA interference (RNAi [...]
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
19/10/2026
FOSTER CITY, Calif., Oct. 19, 2026 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a hematology-focused biopharmaceutical company pursuing more meaningful moments for people living with blood cancer, today [...]
Jemperli (dostarlimab) Approved in the U.S. as First and Only Immunotherapy for Adults with MSI-H/dMMR Locally Advanced Rectal Cancer
19/10/2026
Approval based on AZUR-1 data showing significant proportion of participants with no detectable signs of cancer one year or more after treatment No disease recurrences reported among responders after median follow up of [...]
Kane to Showcase revyve® at Wounds Canada National Hybrid Conference
19/10/2026
Engaging Canadian wound-care professionals, presenting data and discussing biofilm management in clinical practice WINNIPEG, Manitoba, Oct. 19, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the “Company”, “ [...]
Maxim Hair Restoration, a Leading FUE Hair Transplant Provider, Named a 2026 Best of America Small Business Awards Winner
19/10/2026
BASA Awards® recognizes Maxim in the Health Care & Medical Center category New York City, NEW YORK, Oct. 19, 2026 (GLOBE NEWSWIRE) -- Maxim Hair Restoration has been named among the winners of the 2026 Best of [...]
Xealth to Lead Session on AI Applications and Digital Technologies Reshaping Healthcare at IHF World Congress
19/10/2026
SEOUL, South Korea, Oct. 19, 2026 (GLOBE NEWSWIRE) -- Xealth , the leader in digital health orchestration and deployment, today announced that Xealth CEO Mike McSherry will chair a session on innovative applications of [...]
Une thérapie révolutionnaire pour l’insuffisance cardiaque avancée : Repairon renforce son équipe de direction avec la nomination de Detlef Schumann, Ph.D., au poste de directeur des opérations
19/10/2026
Ce dirigeant du secteur biotechnologique apporte une expérience internationale en matière de direction et d’opérations, visant à accélérer le développement clinique, à étendre les activités et à mettre en œuvre des [...]
Groundbreaking therapy for advanced heart failure: Repairon Strengthens Executive Leadership with Appointment of Detlef Schumann, Ph.D. as Chief Operating Officer
19/10/2026
Biotech executive brings global leadership and operations experience to speed clinical development, expand operations, and carry out strategic growth plans. GÖTTINGEN, Germany and PROVIDENCE, R.I., Oct. 19, 2026 (GLOBE [...]
VIRBAC: Solid growth of +7.9% at CERS in YTD September 2026, fueled by double-digit growth of our Supercharge platforms
19/10/2026
End of September 2026 revenue reached €1,168 million : +7.9% at constant exchange rate and scope (at CERS) vs YTD September 2025 +5.9% at actual rates impacted by currency headwinds Balanced growth in both segments: [...]
VIRBAC: Solide croissance de +7,9 % à TCC à fin septembre 2026, portée par la croissance à deux chiffres de nos plateformes Supercharge
19/10/2026
Le chiffre d'affaires à fin septembre 2026 atteint 1 168 millions d'euros : +7,9 % à taux de change et périmètre constants (PCC) par rapport à fin septembre 2025 +5,9 % à taux réels, impacté par des effets de change [...]
Alignment Health Plan and Astrana Health Partner to Expand Access to Trusted Local Care for California Seniors
19/10/2026
New collaboration expands access to multilingual, community-based care across seven Northern and Southern California counties ORANGE, Calif., Oct. 19, 2026 (GLOBE NEWSWIRE) -- Alignment Health Plan, an award-winning [...]
Strata Earns HFMA Peer Review Designation for 13 Consecutive Years
19/10/2026
Recognition reflects Strata’s commitment to delivering customer value and advancing healthcare financial decision-making CHICAGO, Oct. 19, 2026 (GLOBE NEWSWIRE) -- Strata Decision Technology today announced that after [...]
Baylor Genetics to Highlight Clinical and Diagnostic Utility of Genome Sequencing at the 2026 American Society of Human Genetics Annual Meeting
19/10/2026
HOUSTON, Oct. 19, 2026 (GLOBE NEWSWIRE) -- Baylor Genetics , a leading diagnostic genomics partner offering a full spectrum of comprehensive genetic tests and diagnostic services, today announced it will share new [...]
Leads Biolabs' Opamtistomig and LBL-034 Featured in Six Abstracts at 2026 ESMO Congress
19/10/2026
Three Studies Selected for Oral Presentation, Including a Late-Breaking Abstract; Data Highlight Durable Responses and Long-Term Survival Signals Across Immunologically Cold Tumors and Deep, Sustained Responses in [...]
FOXO TECHNOLOGIES INC.’S SUBSIDIARY, MYRTLE RECOVERY CENTERS, INC., ANNOUNCES EXPANSION OF ITS FLAGSHIP FACILITY AND FOCUS ON SUBSTANCE USE DISORDER PATIENTS WITH RELATED MEDICAL CARE NEEDS
19/10/2026
WEST PALM BEACH, FL, Oct. 19, 2026 (GLOBE NEWSWIRE) -- FOXO Technologies Inc.’s (OTC: FOXO) (“FOXO”) is pleased to announce that its subsidiary, Myrtle Recovery Centers, Inc. (“Myrtle”), recently received its license [...]
Phase 3 trial in China successfully confirms ACARIZAX® safety and efficacy in patients with house dust mite allergy
19/10/2026
Inside Information Phase 3 trial with ACARIZAX ® in Chinese participants met the primary objective and showed efficacy in line with previous trials, after only 24-28 weeks of treatment. ACARIZAX ® was shown to be safe [...]

Pages